Commensal bacteria in the gut: learning who our friends are
- PMID: 15703684
- DOI: 10.1097/00001574-200411000-00011
Commensal bacteria in the gut: learning who our friends are
Abstract
Purpose of review: Recent evidence has shown that commensal bacteria regulate intestinal physiology, development, and function. This review focuses on new insights into the effects of these organisms on health and disease.
Recent findings: Gastrointestinal tract development and function is determined by communication between the intestinal epithelium and commensal bacteria. Important regulatory interactions between these cells are being defined with early evidence indicating both beneficial and harmful consequences to the host. A subgroup of these bacteria overlaps with probiotic organisms that have preventative and therapeutic potential for diarrhea, inflammatory bowel disease (IBD), atopy, and other diseases, whereas evidence indicates some "nonpathogenic" commensal bacteria may promote an environment conducive to IBD, cancer, and other diseases.
Summary: Progress in understanding the relation between commensal bacteria and human health is likely to promote the identification of new approaches to disease prevention and treatment.
Similar articles
-
Inflammatory bowel disease, gut bacteria and probiotic therapy.Int J Med Microbiol. 2010 Jan;300(1):25-33. doi: 10.1016/j.ijmm.2009.08.004. Epub 2009 Oct 2. Int J Med Microbiol. 2010. PMID: 19800289 Review.
-
Commensal bacteria (normal microflora), mucosal immunity and chronic inflammatory and autoimmune diseases.Immunol Lett. 2004 May 15;93(2-3):97-108. doi: 10.1016/j.imlet.2004.02.005. Immunol Lett. 2004. PMID: 15158604 Review.
-
The gut microbiota and inflammatory bowel disease.Curr Opin Rheumatol. 2015 Jul;27(4):388-96. doi: 10.1097/BOR.0000000000000192. Curr Opin Rheumatol. 2015. PMID: 26002031 Review.
-
Molecular crosstalk of probiotic bacteria with the intestinal immune system: clinical relevance in the context of inflammatory bowel disease.Int J Med Microbiol. 2010 Jan;300(1):63-73. doi: 10.1016/j.ijmm.2009.08.006. Epub 2009 Oct 13. Int J Med Microbiol. 2010. PMID: 19828372 Review.
-
Therapeutic approaches targeting intestinal microflora in inflammatory bowel disease.World J Gastroenterol. 2006 Jul 28;12(28):4452-60. doi: 10.3748/wjg.v12.i28.4452. World J Gastroenterol. 2006. PMID: 16874854 Free PMC article. Review.
Cited by
-
Disruption of NF-kappaB signalling by ancient microbial molecules: novel therapies of the future?Gut. 2010 Apr;59(4):421-6. doi: 10.1136/gut.2009.179614. Gut. 2010. PMID: 20332512 Free PMC article. Review. No abstract available.
-
Novel perspectives in probiotic treatment: the efficacy and unveiled mechanisms of the physiological functions.Clin J Gastroenterol. 2010 Jun;3(3):117-27. doi: 10.1007/s12328-010-0154-0. Epub 2010 May 8. Clin J Gastroenterol. 2010. PMID: 26190117
-
The canine isolate Lactobacillus acidophilus LAB20 adheres to intestinal epithelium and attenuates LPS-induced IL-8 secretion of enterocytes in vitro.BMC Microbiol. 2015 Jan 16;15(1):4. doi: 10.1186/s12866-014-0337-9. BMC Microbiol. 2015. PMID: 25591990 Free PMC article.
-
Soluble proteins produced by probiotic bacteria regulate intestinal epithelial cell survival and growth.Gastroenterology. 2007 Feb;132(2):562-75. doi: 10.1053/j.gastro.2006.11.022. Epub 2006 Nov 17. Gastroenterology. 2007. PMID: 17258729 Free PMC article.
-
The Fate of Foodborne Pathogens in Manure Treated Soil.Front Microbiol. 2021 Dec 10;12:781357. doi: 10.3389/fmicb.2021.781357. eCollection 2021. Front Microbiol. 2021. PMID: 34956145 Free PMC article. Review.
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials